You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

Incruse and Relvar Ellipta pack shot

Relvar Ellipta in combination with Incruse Ellipta - a straightforward option[1] for your COPD patients suitable for a LAMA in combination with ICS/LABA.


  1. Incruse Ellipta 55 mcg SmPC; GlaxoSmithKline.
Innoviva logo

Adverse events should be reported. Reporting forms and information can be found at
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.

Incruse, Relvar and Ellipta are registered trademarks of the GlaxoSmithKline group of companies.